• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Randomized controlled trial of acyclovir for the prevention of cytomegalovirus infection and disease in liver transplant recipients.

作者信息

Saliba F, Eyraud D, Samuel D, David M F, Arulnaden J L, Dussaix E, Mathieu D, Bismuth H

机构信息

Hepato-Biliary and Liver Transplant Unit, Hôpital Paul Brousse, Villejuif, France.

出版信息

Transplant Proc. 1993 Feb;25(1 Pt 2):1444-5.

PMID:8382876
Abstract
摘要

相似文献

1
Randomized controlled trial of acyclovir for the prevention of cytomegalovirus infection and disease in liver transplant recipients.阿昔洛韦预防肝移植受者巨细胞病毒感染和疾病的随机对照试验。
Transplant Proc. 1993 Feb;25(1 Pt 2):1444-5.
2
Cytomegalovirus disease in liver transplant recipients: impact of acyclovir prophylaxis.肝移植受者的巨细胞病毒疾病：阿昔洛韦预防的影响
Transplant Proc. 1993 Jun;25(3):2282-3.
3
Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.在巨细胞病毒血清学阳性的肝移植受者中，静脉注射更昔洛韦诱导治疗后，口服更昔洛韦与口服阿昔洛韦用于长期预防巨细胞病毒疾病的随机对照试验。
Transplantation. 2003 Jan 27;75(2):229-33. doi: 10.1097/01.TP.0000040601.60276.96.
4
[Open clinical trial with oral acyclovir for the prophylaxis of disease by Cytomegalovirus in low risk liver transplant recipients].[口服阿昔洛韦预防低风险肝移植受者巨细胞病毒疾病的开放性临床试验]
Enferm Infecc Microbiol Clin. 1999 Oct;17(8):382-5.
5
Acyclovir in preventing cytomegalovirus infection in kidney transplant recipients: a case-controlled study.
Transplant Proc. 1993 Feb;25(1 Pt 2):1431-3.
6
Viral prophylaxis in hepatic transplantation: preliminary report of a randomized trial of acyclovir and gancyclovir.
Transplant Proc. 1993 Apr;25(2):1935-7.
7
Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.口服更昔洛韦或口服阿昔洛韦预防器官移植受者原发性巨细胞病毒病
Transpl Infect Dis. 2000 Sep;2(3):112-7.
8
A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study Group.
Transplant Proc. 1994 Oct;26(5 Suppl 1):23-7.
9
Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.更昔洛韦与阿昔洛韦预防异基因移植后巨细胞病毒血症的随机临床试验。
Bone Marrow Transplant. 2002 Dec;30(12):945-51. doi: 10.1038/sj.bmt.1703770.
10
Prevention of cytomegalovirus disease in heart transplant recipients by prophylaxis with cytomegalovirus hyperimmune globulin plus oral acyclovir.通过使用巨细胞病毒超免疫球蛋白加口服阿昔洛韦进行预防，防止心脏移植受者发生巨细胞病毒疾病。
Transplant Proc. 1990 Oct;22(5):2322-3.

引用本文的文献

1
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.对巨细胞病毒血症进行抢先治疗以预防实体器官移植受者的巨细胞病毒疾病。
Cochrane Database Syst Rev. 2025 Jan 14;1(1):CD005133. doi: 10.1002/14651858.CD005133.pub4.
2
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.抗 CMV 病的抗病毒药物用于预防实体器官移植受者。
Cochrane Database Syst Rev. 2024 May 3;5(5):CD003774. doi: 10.1002/14651858.CD003774.pub5.
3
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.
对巨细胞病毒血症进行抢先治疗以预防实体器官移植受者的巨细胞病毒疾病。
Cochrane Database Syst Rev. 2013 Feb 28;2013(2):CD005133. doi: 10.1002/14651858.CD005133.pub3.
4
Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients.儿科移植受者巨细胞病毒感染的当前预防和治疗管理策略。
Paediatr Drugs. 2002;4(5):279-90. doi: 10.2165/00128072-200204050-00001.
5
New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.实体器官移植受者巨细胞病毒感染及疾病的预防和治疗新策略。
Clin Microbiol Rev. 2000 Jan;13(1):83-121, table of contents. doi: 10.1128/CMR.13.1.83.
6
Infections in solid-organ transplant recipients.实体器官移植受者的感染
Clin Microbiol Rev. 1997 Jan;10(1):86-124. doi: 10.1128/CMR.10.1.86.
7
Atypical oral presentation of herpes simplex virus infection in a patient after orthotopic liver transplantation.原位肝移植术后患者单纯疱疹病毒感染的非典型口腔表现
Eur Arch Otorhinolaryngol. 1994;251(5):301-3. doi: 10.1007/BF00181890.
8
Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.阿昔洛韦。对其抗病毒活性、药代动力学特性及治疗效果的重新评估。
Drugs. 1994 Jan;47(1):153-205. doi: 10.2165/00003495-199447010-00009.